COPYRIGHT© 2018 吉林紫鑫药业股份有限公司
Jilin figure at the international conference Jilin Zixin Pharmaceutical became the only authorized support unit of the sixth ple
This newspaper, Zixinhong, fresh ginseng honey tablets, jade red face, red ginseng gelatin cake, ginseng, ginseng, binaural drink, ginseng enzyme fruit tree fermented beverage... June 1st - 4th, International Organization for Standardization in Beijing At the sixth plenary session of the Technical Committee of the Chinese Medicine (tentative name) (ISO/TC249), Jilin Zixin Pharmaceutical became the only authorized support unit of the conference, and the scene of the meeting flashed Jilin. Wang Guoqiang, deputy director of the State Health Planning Commission and director of the State Administration of Traditional Chinese Medicine, Yu Xinli, deputy director of the National Standardization Administration, Yu Wenming, deputy director of the State Administration of Traditional Chinese Medicine, Lu Aiping, head of the Chinese delegation, and Dr. David Trevor Graham, chairman of ISO/TC249 (Australia) and other participants attended the meeting.
According to reports, in 2009, with the wide spread and application of Chinese medicine in the world, the demand for international standards of Chinese medicine has become increasingly prominent. ISO/TC249 was formally established to establish a new pattern of TCM standardization and realize the good wishes of TCM to serve the health of the people of the world. This meeting is the first time since China hosted the first plenary meeting of ISO/TC249 in 2010, and once again won the right to host the meeting. The conference was attended by 12 member states including China, Australia, Canada, Germany, Japan, South Korea and ISO headquarters, the World Federation of Acupuncture Associations, the World Federation of Chinese Medicine Societies, and ISO/TC215. It is the most in history. The Chinese representative is composed of 138 experts from 17 provinces, municipalities, autonomous regions and Hong Kong and Macao Special Administrative Regions.
Jilin Zixin Pharmaceutical Co., Ltd. is a high-tech joint-stock enterprise integrating scientific research, production, sales and Chinese herbal medicines with the three major industries of Chinese patent medicine, ginseng industry and genetic sequencer as the mainstay in Jilin Province. This time, Jilin Zixin Pharmaceutical Co., Ltd., as the outstanding pharmaceutical company in China, became the only authorized support unit of the conference.
"Using the ISO/TC249 platform, actively participating in the research and development of international standards for ginseng and its products, and letting the world enjoy high-quality ginseng in China is the mission of Zixin Pharmaceutical." Chairman of Jilin Zixin Pharmaceutical Co., Ltd. General Manager Guo Chunlin said that Zixin Pharmaceutical will also actively participate in the research and development of ISO/TC249 Chinese medicine international standards, in order to enable China's proprietary Chinese medicines to go abroad, participate in international competition, and better serve the health of all human beings. The status of the sovereign state of Chinese medicine, the implementation of China's "One Belt, One Road" strategic concept, and make due contributions, "we also hope that the next time China will hold the ISO/TC249 plenary meeting, it can be held in Jilin Province, let the province The Chinese medicine industry is heading for the world."